Literature DB >> 23800338

Relatively high prevalence of drug resistance among antiretroviral-naive patients from Henan, Central China.

Lingnuo Li1, Binlian Sun, Haiyan Zeng, Zhiwu Sun, Guoqing Sun, Rongge Yang.   

Abstract

To elucidate the prevalence of HIV-1 subtypes and transmitted drug resistance in Henan, central China, HIV-1-positive blood samples from 187 antiretroviral-naive patients were collected in our study from August 2009 to November 2010. Subtype B' (92.0%, 172 of 187) remains the predominant HIV-1 subtype in Henan province and was prevalent in all risk populations and geographic regions. Of 98 pol sequences 67 (68.4%) harbored drug resistance mutations, and only 14 (14.3%, 14 of 98) sequences have mutations associated with significantly reduced phenotypic susceptibility to antiretroviral drugs. The unexpectedly high percentage of drug resistance in Henan province is mainly due to the prevalence of minor mutations in the protease and integrase regions, especially A71T/V and L68V/I/IM/LV. In all, we detected a relatively high prevalence of drug resistance with unique mutation distributions among antiretroviral-naive patients from Henan province.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800338      PMCID: PMC3910477          DOI: 10.1089/aid.2013.0144

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Explosive HIV-1 subtype B' epidemics in Asia driven by geographic and risk group founder events.

Authors:  Yue Li; Rie Uenishi; Saiki Hase; Huanan Liao; Xiao-Jie Li; Takayo Tsuchiura; Kok Keng Tee; Oliver G Pybus; Yutaka Takebe
Journal:  Virology       Date:  2010-05-01       Impact factor: 3.616

2.  Correlates of HIV infection among former blood/plasma donors in rural China.

Authors:  Guoping Ji; Roger Detels; Zunyou Wu; Yueping Yin
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

3.  [Prevalence of HIV-1 drug resistance from those newly confirmed cases in Henan province, 2010-2011].

Authors:  Xiu-juan Xue; Hui Xing; Wei-guo Cui; Jia Liu; Guo-qing Sun; Cui He; Sui-an Tian; Chun-hua Liu; Zhe Wang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-09

4.  HIV-1 infection in commercial plasma donors in China.

Authors:  Z Wu; Z Liu; R Detels
Journal:  Lancet       Date:  1995-07-01       Impact factor: 79.321

5.  [Study on the transmission of drug resistant human immunodeficiency virus-1 in Henan province].

Authors:  Yuan Yuan; Xin-liang Cao; Hong-wei Liu; Hui Xing; Chun-hua Liu; Wei-guo Cui; Ding-yong Sun; Ning Li; Qian Zhu; Zhe Wang; Yi-ming Shao
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2009-11

6.  Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.

Authors:  Luis M F Gonzalez; André F Santos; Ana B Abecasis; Kristel Van Laethem; Esmeralda A Soares; Koen Deforche; Amilcar Tanuri; Ricardo Camacho; Anne-Mieke Vandamme; Marcelo A Soares
Journal:  J Antimicrob Chemother       Date:  2008-03-20       Impact factor: 5.790

7.  The Chinese free antiretroviral treatment program: challenges and responses.

Authors:  Fujie Zhang; Jessica E Haberer; Yu Wang; Yan Zhao; Ye Ma; Decai Zhao; Lan Yu; Eric P Goosby
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

8.  Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.

Authors:  J Liu; J Yue; S Wu; Y Yan
Journal:  Arch Virol       Date:  2007-07-06       Impact factor: 2.574

9.  The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China.

Authors:  Lingjie Liao; Hui Xing; Hong Shang; Jingyun Li; Ping Zhong; Laiyi Kang; Hua Cheng; Xuefeng Si; Shulin Jiang; Xinping Li; Yiming Shao
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

10.  Human immunodeficiency virus type 1 subtypes prevalence in central China.

Authors:  Fei Zhao; Zhe Wang; Wen-Jie Li
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more
  7 in total

1.  Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.

Authors:  Bum Sik Chin; Hyoung-Shik Shin; Gayeon Kim; Gabriel A Wagner; Sara Gianella; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-28       Impact factor: 2.205

2.  Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China.

Authors:  Tingting Li; Feng Qian; Ting Yuan; Weilu Xu; Li Zhu; Jinlong Huang; Haiyan Wang; Yueping Zhu; Yinling Wang; Xiaohong Li; Saihong Gu; Zhuqing Tan; Hui Chen; Xiangrong Luo; Wei Zhu; Wenjuan Lu; Ping Xu; Ming Li; Yuying Chen; Yong Gao; Rongge Yang; Chuanwu Zhu; Binlian Sun
Journal:  Virol Sin       Date:  2017-08-07       Impact factor: 4.327

3.  The first third-generation HIV-1 circulating recombinant form (CRF114_0155) identified in central China.

Authors:  Yang Li; Yan Zhang; Hongye Wang; Long Liu; Hui Chen; Shuanhu Zhang; Wenying Wu; Rongge Yang
Journal:  Arch Virol       Date:  2021-10-04       Impact factor: 2.574

4.  Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.

Authors:  Ke Zhao; Wenzhen Kang; Qingquan Liu; Yuan Li; Qing Liu; Wei Jiang; Yan Zhuang; Zisheng Guo; Zhuoran Yu; Xinhong Li; Chunfu Wang; Na Yao; Yongtao Sun
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

5.  HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China.

Authors:  Xinli Lu; Xianjiang Kang; Yongjian Liu; Ze Cui; Wei Guo; Cuiying Zhao; Yan Li; Suliang Chen; Jingyun Li; Yuqi Zhang; Hongru Zhao
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

6.  High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China.

Authors:  Qicai Xuan; Shuwen Liang; Weihong Qin; Shuting Yang; A-Mei Zhang; Ting Zhao; Hui Su; Zhiqing Xia; Binghui Wang; Xueshan Xia
Journal:  BMC Infect Dis       Date:  2018-05-08       Impact factor: 3.090

7.  Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.

Authors:  Xianfeng Wang; Xiaosong Liu; Feng Li; Hong Zhou; Jiefang Li; Yingying Wang; Lihua Liu; Shujun Liu; Yi Feng; Ning Wang
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.